When Switching Makes Sense and When It Doesnt Switching to tirzepatide may be a good option if: Weight loss has stalled despite consistency Side effects are limiting progress Appetite control remains a challenge Staying on semaglutide may make sense if: Weight loss is steady Side effects are minimal The current dose is working well The right choice depends on how your body is responding, not on comparisons alone
You might notice improvements like feeling happier, having more energy, being less tired, and just generally feeling better
We recommend you get booster shots routinely to avoid the impacts from fading
After the initial deductible ($590 in 2025), patients enter the initial coverage phase with tiered copays
This is partly because the body's weight set point defends against the lower weight, and partly because GLP-1 receptors in the brain that were being continuously stimulated are no longer activated
The Precision Peptide Genetic Test reveals predispositions in key GLP-1 pathway variantsincluding GLP1R rs6923761 and GIPR rs1800437that relate to how your body's GLP-1 signaling responds to consistent drug dosing and timing